The Tonix Pharmaceuticals Holding Corp (TNXP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $75,605.80, representing a +1.59M% increase from the current price of $4.74. Tonix Pharmaceuticals Holding Corp. (TNXP) has a median analyst price target of $26 with a forecast range of $18-$65 from 4 Wall St analysts. On the analyst front, the consensus recommendation is a Strong Buy, with an average 12-month price target near $44 and a notably wide range from roughly $22 to $65. Based on short-term price targets offered by six analysts, the average price target for Tonix Pharmaceuticals Holding Corp. comes to $38.17. The forecasts range from a low of $18.00 to a high. Stock forecasts and analyst price target predictions for Tonix Pharmaceuticals Holding Corp. (TNXP) stock, with detailed revenue and earnings estimates. According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Tonix Pharmaceuticals is $22.33, with a high forecast of $27.00 and a low forecast of $18.00. Based on 4 Wall Street analysts offering 12 month price targets for Tonix Pharma in the last 3 months. The average price target is $32.75 with a high forecast of $65.00 and a low forecast of $18.00. Given the current short-term trend, the stock is expected to fall -61.31% during the next 3 months and, with a 90% probability hold a price between $1.72 and $2.50 at the end of this 3-month period. Find the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock quote, history, news and other vital information to help you with your stock trading and investing. Should You Buy or Sell Tonix Pharmaceuticals Stock? Get The Latest TNXP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.